234 related articles for article (PubMed ID: 7574856)
41. Effect of testosterone therapy for delayed growth and puberty in boys with inflammatory bowel disease.
Mason A; Wong SC; McGrogan P; Ahmed SF
Horm Res Paediatr; 2011; 75(1):8-13. PubMed ID: 20664179
[TBL] [Abstract][Full Text] [Related]
42. A specific aromatase inhibitor and potential increase in adult height in boys with delayed puberty: a randomised controlled trial.
Wickman S; Sipilä I; Ankarberg-Lindgren C; Norjavaara E; Dunkel L
Lancet; 2001 Jun; 357(9270):1743-8. PubMed ID: 11403810
[TBL] [Abstract][Full Text] [Related]
43. Effect of low dose oxandrolone and testosterone treatment on the pituitary-testicular and GH axes in boys with constitutional delay of growth and puberty.
Crowne EC; Wallace WH; Moore C; Mitchell R; Robertson WH; Holly JM; Shalet SM
Clin Endocrinol (Oxf); 1997 Feb; 46(2):209-16. PubMed ID: 9135704
[TBL] [Abstract][Full Text] [Related]
44. Treatment and disease effects on short-term growth and adult height in children and adolescents with 21-hydroxylase deficiency.
Hauffa BP; Winter A; Stolecke H
Klin Padiatr; 1997; 209(2):71-7. PubMed ID: 9113619
[TBL] [Abstract][Full Text] [Related]
45. Lack of benefit of clonidine treatment for short stature in a double-blind, placebo-controlled trial.
Pescovitz OH; Tan E
Lancet; 1988 Oct; 2(8616):874-7. PubMed ID: 2902319
[TBL] [Abstract][Full Text] [Related]
46. Novel treatment of short stature with aromatase inhibitors.
Dunkel L; Wickman S
J Steroid Biochem Mol Biol; 2003 Sep; 86(3-5):345-56. PubMed ID: 14623531
[TBL] [Abstract][Full Text] [Related]
47. Outcome in tall stature. Final height and psychological aspects in 220 patients with and without treatment.
Binder G; Grauer ML; Wehner AV; Wehner F; Ranke MB
Eur J Pediatr; 1997 Dec; 156(12):905-10. PubMed ID: 9453370
[TBL] [Abstract][Full Text] [Related]
48. Failure to improve height prediction in short-stature pubertal adolescents by inhibiting puberty with luteinizing hormone-releasing hormone analogue.
Lindner D; Job JC; Chaussain JL
Eur J Pediatr; 1993 May; 152(5):393-6. PubMed ID: 8319702
[TBL] [Abstract][Full Text] [Related]
49. Oxandrolone induces a sustained rise in physiological growth hormone secretion in boys with constitutional delay of growth and puberty.
Stanhope R; Hindmarsh P; Pringle PJ; Holownia P; Honour J; Brook CG
Pediatrician; 1987; 14(3):183-8. PubMed ID: 3453497
[TBL] [Abstract][Full Text] [Related]
50. Low-dose testosterone effect on somatic growth.
Rosenfield RL
Pediatrics; 1986 Jun; 77(6):853-7. PubMed ID: 3714378
[TBL] [Abstract][Full Text] [Related]
51. Final height data, body composition and glucose metabolism in growth hormone-treated short children born small for gestational age.
Hokken-Koelega AC; van Pareren Y; Sas T; Arends N
Horm Res; 2003; 60 Suppl 3():113-4. PubMed ID: 14671407
[TBL] [Abstract][Full Text] [Related]
52. The results of short-term (6 months) high-dose testosterone treatment on bone age and adult height in boys of excessively tall stature.
Brämswig JH; von Lengerke HJ; Schmidt H; Schellong G
Eur J Pediatr; 1988 Nov; 148(2):104-6. PubMed ID: 3234428
[TBL] [Abstract][Full Text] [Related]
53. Treatment of tall stature in boys: comparison of two different treatment regimens.
Reinehr T; Gueldensupp M; Wunsch R; Bramswig JH
Horm Res Paediatr; 2011; 76(5):343-7. PubMed ID: 22024831
[TBL] [Abstract][Full Text] [Related]
54. The effects of testosterone and dihydrotestosterone on hypothalamic regulation of growth hormone secretion.
Eakman GD; Dallas JS; Ponder SW; Keenan BS
J Clin Endocrinol Metab; 1996 Mar; 81(3):1217-23. PubMed ID: 8772602
[TBL] [Abstract][Full Text] [Related]
55. Early morning plasma testosterone is an accurate predictor of imminent pubertal development in prepubertal boys.
Wu FC; Brown DC; Butler GE; Stirling HF; Kelnar CJ
J Clin Endocrinol Metab; 1993 Jan; 76(1):26-31. PubMed ID: 8421096
[TBL] [Abstract][Full Text] [Related]
56. Inhibition of estrogen biosynthesis with a potent aromatase inhibitor increases predicted adult height in boys with idiopathic short stature: a randomized controlled trial.
Hero M; Norjavaara E; Dunkel L
J Clin Endocrinol Metab; 2005 Dec; 90(12):6396-402. PubMed ID: 16189252
[TBL] [Abstract][Full Text] [Related]
57. Treatment of hypogonadal adolescent boys with long acting subcutaneous testosterone pellets.
Zacharin MR; Warne GL
Arch Dis Child; 1997 Jun; 76(6):495-9. PubMed ID: 9245845
[TBL] [Abstract][Full Text] [Related]
58. Treatment of delayed male puberty: efficacy of aromatase inhibition.
Dunkel L; Wickman S
J Pediatr Endocrinol Metab; 2001; 14 Suppl 6():1541-6. PubMed ID: 11837512
[TBL] [Abstract][Full Text] [Related]
59. Oxandrolone in constitutionally delayed growth, a longitudinal study up to final height.
Joss EE; Schmidt HA; Zuppinger KA
J Clin Endocrinol Metab; 1989 Dec; 69(6):1109-15. PubMed ID: 2584350
[TBL] [Abstract][Full Text] [Related]
60. High dose growth hormone treatment induces acceleration of skeletal maturation and an earlier onset of puberty in children with idiopathic short stature.
Kamp GA; Waelkens JJ; de Muinck Keizer-Schrama SM; Delemarre-Van de Waal HA; Verhoeven-Wind L; Zwinderman AH; Wit JM
Arch Dis Child; 2002 Sep; 87(3):215-20. PubMed ID: 12193430
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
